More trouble at PPL
PPL Therapeutics, the Scottish-based biotechnology firm responsible for creating Dolly the sheep, announced last week that it is to close the stem cell research side of its business based at Roslin, near Edinburgh, after no buyer had been found for it. In a statement issued by the company, it was...
Comment
Delays in US stem cell debate
by Dr Jess Buxton
Whatever happened to the US debate on embryo stem cell research and therapeutic cloning? Senators were due to consider two rival bills on cloning for medical research purposes back in June, but both were eventually withdrawn following procedural disputes. The confusion was seen as a blow to President Bush, who...